2nd dose of semaglutide Ozempic® Pen Dosing New York's Compounded Semaglutide Weight

Compounded versions are not FDA-approved and have not undergone clinical trials

Who Might Be a Good Candidate

Our approach includes: Thorough case evaluation using our medical and legal expertise Collaboration with top medical experts for case building and testimony A track record of success in complex pharmaceutical cases National reach through class actions and partnerships with other firms Were committed to holding pharmaceutical companies accountable and fighting for fair compensation for our clients

Moderate weight loss was found to be a common side effect of the drug, and the FDA approved a different formulation of semaglutide, called Wegovy, for that purpose in 2021